SecBot SecBot
DEF 14A ·Filed Oct 7, 2026

XWEL

XWELL, Inc.
NEUTRAL
Impact 5/10
Horizonweeks Processed19d ago SEC0001104659-26-114457
Definitive proxy statement
Actionable Insight • Neutral

The sale is highly likely to be approved given the 28.1% committed support from insiders and the activist holder. Post-close, XWELL will be a cash-rich shell with a tiny revenue base (~$2.3M trailing twelve months), creating a blank-check-like vehicle for a transformative acquisition. Monitor for any competing bids or shareholder litigation before the October 28 vote.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+5d ⚠ clustered
XWEL ▼ -18.48% at T+5d
NEUTRAL call -18.48% · α vs SPY -18.20% · entry $0.9200 → $0.7500
Next anchor: T+20d in 8d
Latest observation: T+11 -26.59% FF3 residual α
Entry = T+0 close
Oct 7, 2026
via day close
T+1d
-10.87%
call -10.87% · α -11.47%
$0.8200
settled 19d ago
T+5d
-18.48%
call -18.48% · α -18.20%
$0.7500
settled 13d ago
T+20d
Pending
in 8d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

XWELL, Inc. is seeking stockholder approval at a special meeting on October 28, 2026, for the sale of its XpresSpa and XpresTest subsidiaries to Express Wellness Group, LLC for a base purchase price of $13 million. The company will retain its small ex-airport health and wellness retail business and intends to use the net proceeds to pursue strategic acquisitions in unrelated industries. The filing also includes advisory votes on executive compensation related to the sale and an increase in shares reserved under the 2020 Equity Incentive Plan.

Key Facts

  • Base purchase price of $13,000,000 for the sale of XpresSpa and XpresTest subsidiaries.
  • Special stockholder meeting scheduled for October 28, 2026, to vote on the sale.
  • Support parties, including directors, officers, and American Ventures LLC Series XXIV XWELL, own approximately 28.1% of outstanding shares and have agreed to vote in favor of the sale.
  • As of the record date (October 7, 2026), 9,970,883 shares of common stock were outstanding.
  • The company intends to retain net proceeds to fund its remaining ex-airport business and pursue strategic acquisitions.
  • XpresTest repurchased all outstanding restricted stock awards for approximately $2.7 million on October 5, 2026.
  • A prior SC 13D/A filing (September 9, 2026) disclosed a support agreement between American Ventures LLC Series XXIV XWELL and the Buyer, with the stockholder agreeing to vote its converted shares in favor of the sale.

Financial Impact

Base purchase price of $13,000,000, subject to adjustments for net working capital, indebtedness, and cash. Total value to XWELL estimated at $30.1 million including pre-closing cash sweep, with $2.65 million placed in escrow.

revenuecashdebt

Risk Factors

  • Buyer has not obtained definitive financing commitments, creating execution risk despite an unconditional obligation to close.
  • Post-sale, the company will lose its entire senior management team and must recruit new leadership.
  • The company has no definitive plan for the use of proceeds, and the remaining ex-airport business is very small.
  • Failure to obtain required lease consents from airport authorities could delay or prevent closing.

Investment Themes

Services

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEF 14A Filing (Primary)0001104659-26-114457
Document: 0001104659-26-114457-index-headers.html0001104659-26-114457
Document: 0001104659-26-114457-index.html0001104659-26-114457
Document: 0001104659-26-114457.txt0001104659-26-114457
10 reports for XWEL
Performance horizon
100% Hit rate @ T+60 4 of 4 directional calls Went positive at some point 4 of 5 best @ T+60▲ +9.63%Apr 16, 2026
Filters
Rows
Reports for XWEL — sortable, filterable
TypeNow
Oct 21, 2026
5d ago
DEFA14A
NEUTRAL ★ 3/10
$0.7000awaiting T+60—$0.6800 (−2.86%)
Oct 20, 2026
6d ago
8-K
BEARISH ★ 7/10
$0.6530awaiting T+60—$0.6800 (−4.13%)
Oct 7, 2026
19d ago
DEF 14A
NEUTRAL ★ 5/10
$0.9200awaiting T+60—$0.6800 (−26.09%)
Oct 7, 2026
19d ago
8-K
NEUTRAL ★ 4/10
$0.9200awaiting T+60—$0.6800 (−26.09%)
Aug 5, 2026
11w ago
8-K
NEUTRAL ★ 3/10
$1.00awaiting T+60—$0.6800 (−32.00%)
Apr 16, 2026
27w ago
EFFECT
BEARISH ★ 7/10
$1.04 $0.9399▲ +9.63%▲ +16.67%$0.6800 (+34.62%)
Apr 1, 2026
29w ago
S-3
BEARISH ★ 7/10
$1.07 $1.04▲ +2.80%▲ +16.96%$0.6800 (+36.45%)
Apr 1, 2026
29w ago
8-K
BEARISH ★ 8/10
$1.07 $1.04▲ +2.80%▲ +16.96%$0.6800 (+36.45%)
Apr 1, 2026
29w ago
Press Release
BEARISH ★ 7/10
$1.07 $1.04▲ +2.80%▲ +16.96%$0.6800 (+36.45%)
Feb 25, 2026
34w ago
8-K
NEUTRAL ★ 5/10
$1.21 $1.46▲ +20.66%▲ +13.71%$0.6800 (−43.80%)
Showing 10 of 10

US Market Status

Market Closed — Opens Wed (12h 41m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 7, 2026